行情

FBIO

FBIO

Fortress Biotech
NASDAQ

实时行情|Nasdaq Last Sale

1.850
-0.040
-2.12%
盘后: 1.740 -0.11 -5.95% 18:17 04/01 EDT
开盘
1.900
昨收
1.890
最高
1.940
最低
1.740
成交量
44.44万
成交额
--
52周最高
3.110
52周最低
1.040
市值
1.45亿
市盈率(TTM)
-2.6200
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测FBIO价格均价为9.20,最高价位19.00,最低价为4.000。

EPS

FBIO 新闻

更多
  • 沪指低开高走 疫情数据双重打击、隔夜美股重挫4.4%
  • 新浪财经 · 12分钟前
  • 美国3月枪支销量突破250万 同比飙升85%
  • 新浪财经 · 56分钟前
  • 百度发行10亿美元新债 穆迪授予A3评级
  • 新京报网 · 1小时前
  • 海上石油库存逼近2009年的纪录高位 因库存过剩加剧
  • 新浪财经综合 · 1小时前

所属板块

制药
-2.46%
制药与医学研究
-2.91%

热门股票

代码
价格
涨跌幅

FBIO 简况

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
展开

微牛提供Fortress Biotech Inc(NASDAQ-FBIO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的FBIO股票新闻,以帮助您做出投资决策。